Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-22-202902
Filing Date
2022-07-27
Accepted
2022-07-27 10:25:12
Documents
88
Period of Report
2022-05-31

Document Format Files

Seq Description Document Type Size
1 10-K d366491d10k.htm   iXBRL 10-K 2346183
2 EX-21 d366491dex21.htm EX-21 17234
3 EX-23 d366491dex23.htm EX-23 1786
4 EX-24 d366491dex24.htm EX-24 10484
5 EX-31.1 d366491dex311.htm EX-31.1 10977
6 EX-31.2 d366491dex312.htm EX-31.2 10999
7 EX-32 d366491dex32.htm EX-32 5062
13 GRAPHIC g366491dsp28.jpg GRAPHIC 44746
  Complete submission text file 0001193125-22-202902.txt   11176169

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA neog-20220531.xsd EX-101.SCH 62930
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE neog-20220531_cal.xml EX-101.CAL 55611
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE neog-20220531_def.xml EX-101.DEF 483431
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE neog-20220531_lab.xml EX-101.LAB 604896
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE neog-20220531_pre.xml EX-101.PRE 542118
82 EXTRACTED XBRL INSTANCE DOCUMENT d366491d10k_htm.xml XML 2127035
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 10-K | Act: 34 | File No.: 000-17988 | Film No.: 221109369
SIC: 2835 In Vitro & In Vivo Diagnostic Substances